April 18, 2024 BY Elizabeth Anderson
Eli Lilly’s Zepbound a Possible Treatment for Sleep Apnoea
The company markets this drug as Zepbound® in the US and as Mounjaro® in some international markets. These outcomes add to the merits of medicines such as Zepbound and Novo Nordisk’s (NVO) Ozempic in the treatment of obesity and diabetes. Despite supply, cost, and health insurance issues, these drugs remain in high demand worldwide. Lilly…
Read more